The University of Chicago Header Logo

Connection

Thinle Chodon to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Thinle Chodon has written about Drug Evaluation, Preclinical.
Thinle Chodon
Connection Strength
0.095
Drug Evaluation, Preclinical
  1. The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations. Clin Cancer Res. 2010 Dec 15; 16(24):6040-8.
    View in: PubMed
    Score: 0.095
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.